JC

Jeremy Curnock-Cook

AVITA Medical, Inc. | Non-Executive Director
Mr Curnock Cook was head of the life science private equity team at Rothschild Asset Management in the UK and is an active investor in the Australian life science sector. At Rothschild, Mr Curnock Cook was responsible for the launch of the first dedicated biotechnology fund for the Australian market. Over his 40-year career, Mr Curnock Cook has specialised in creating value in emerging biotech enterprises, through active participation with management. He has served on over 40 boards in various roles, including chair of private and public biotechnology companies listed on NASDAQ, AMEX, LSE, TSX and ASX. He is currently Managing Director of BioScience Managers, and sits on the board of Avita Medical, Rex Bionics Pty, Humanetix Ltd, Marine Department Ltd, Cambridge Respiratory Innovations Ltd, and Sea Dragon Ltd. Mr Curnock Cook was previously a director of Bioxyne Limited and Phylogica Limited.

Companies and Roles

Company
Title
Tenure
Since
AVH
AVITA Medical, Inc.
  • Non-Executive Director
11yrs, 9mthOct 2012
ADR
Adherium Limited
  • Non-Executive Director
9yrs, 3mthApr 2015

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
AVH
AVITA Medical, Inc.
07/06/2420,614N/A14,534N/A
ADR
Adherium Limited
30/08/232,992,539N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
AVH
AVITA Medical, Inc.
07/06/24
Exercise
6,175$2.860$17,660Conversion of securities
AVH
AVITA Medical, Inc.
07/06/24
Issued
6,175$2.860$17,660Conversion of securities
AVH
AVITA Medical, Inc.
06/06/24
Issued
9,200$2.830$26,036Issue of securities
AVH
AVITA Medical, Inc.
06/06/24
Issued
3,943$2.830$11,158Issue of options
AVH
AVITA Medical, Inc.
22/12/23
Sell
2,500$12.048$30,120As advised by the company